Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Nexxt Spine is Granted FDA Clearance for New Spinal Implants Made of Solvay’s Zeniva PEEK

September 19, 2012 10:54 am | by Solvay Specialty Polymers | News | Comments

Nexxt Spine LLC, a Fishers, Ind.-based manufacturer of spinal implants and instrumentation, has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its new Honour™ cervical spacer and lumbar spacer implants made of Zeniva® polyetheretherketone (PEEK) rods from Solvay Specialty Polymers USA, LLC. Zeniva® PEEK – part of Solvay’s line of Solviva® Biomaterials...

UL and AAMI to Develop Interoperability Standards

September 18, 2012 3:14 pm | by Underwriters Laboratories | News | Comments

With the goal of improving patient safety and healthcare efficiency, AAMI and UL (Underwriters Laboratories) are joining forces to develop a suite of standards on medical device interoperability-one of the biggest challenges facing the modern healthcare community. The collaboration is a first for AAMI and UL, and comes at a time when many healthcare facilities and manufacturers are grappling...

Alphatec Spine Releases Alphatec NEXoss Nanostructure Bio-Active Matrix and Announces the First Patient Implant

September 18, 2012 10:43 am | by GLOBE NEWSWIRE | News | Comments

Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today the first clinical use of Alphatec NEXoss, a next generation synthetic bone graft indicated for use in posterolateral spine fusions...


K2M Receives Pediatric Clearance for MESA & Rail 4D Spinal Systems

September 18, 2012 9:33 am | by K2M | News | Comments

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that it has received an additional clearance to treat adolescent idiopathic scoliosis. The pediatric clearance applies to the company’s MESA® Deformity (ø5.5 mm)...

MDET: A New Acronym to Learn

September 18, 2012 9:17 am | by PRNewswire | News | Comments

Each Autumn, with an eye on the winter months ahead, squirrels gather nuts to prepare for the inevitable change. Hospitals, medical facilities, doctors and long term care facilities may be doing the same this Fall, stocking shelves and purchasing items from their wish list and budgets before a new tax on most medical products goes into effect. 

Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections

September 18, 2012 7:14 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Sept. 18, 2012 /- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious diseases and unmet medical needs, today announced that it has initiated efforts to develop a monoclonal antibody (mAb) therapy for the treatment of acinetobacter infections. Many strains of Acinetobacter are multidrug-resistant...

First Cancer Patients in Southern Hemisphere Receive Treatment with Elekta's Agility Beam-shaping Innovation for Radiotherapy

September 14, 2012 5:07 pm | by PRNewswire | News | Comments

Transitioning from two Siemens treatment machines to two Elekta Synergy® radiotherapy systems equipped with Agility™* 160-leaf multi-leaf collimator (MLC), physicians at the Riverina Cancer Care Centre (RCCC) have been able to decrease beam delivery time by up to seven minutes for a variety of cancers. The RCCC treated its first patients using an Agility-equipped Elekta Synergy system...

Convatec Launches New Aquacel Ag Extra Wound Dressing with Hydrofiber Technology for at Risk And Infected Wounds

September 14, 2012 4:48 pm | by ConvaTec | News | Comments

ConvaTec, a world-leading developer of innovative medical technologies for community and hospital care, today announced the U.S. introduction of AQUACEL® Ag EXTRA™ wound dressing, incorporating the market-leading and proprietary Hydrofiber® Technology. The new dressing incorporates strengthening fibers, making it especially appropriate for managing highly exuding wounds...


First Long-Term Study Evaluating the Use of Plasma Energy to Treat Endometrioma

September 14, 2012 4:37 pm | News | Comments

At the 21st Annual European Society for Gynaecological Endoscopy (ESGE) Congress held in Paris, the results were presented from a three-year, cohort study, titled Postoperative Recurrences and Fertility Following Endometrioma Ablation Using Plasma Energy: Retrospective Assessment of a 3-Year Experience, that retrospectively assessed postoperative ovarian endometriomas recurrence and fertility.

Corentec America Launches New Lospa Knee System

September 14, 2012 3:42 pm | by Corentec America | News | Comments

Corentec America, Inc., a wholly-owned subsidiary of Seoul-based Corentec Co., Ltd., has announced that the Company has received FDA clearance to market the its novel Lospa Knee System® in the United States. The innovative Knee Joint Replacement System is available now, along with the currently available Total Hip Replacement System, and a Pedicle Screw System for spine.

Silicon Nitride Demonstrates Statistical Superior Osteointegration and Anti-Infective Biomaterial Properties

September 14, 2012 3:19 pm | by Amedica Corporation | News | Comments

Amedica Corporation, a spinal and reconstructive implant manufacturer, announced today the publication of two peer-reviewed studies conducted at Brown University that demonstrate the superior osteointegration and bacterial-resistant properties of its proprietary Silicon Nitride (Si3N4) biomaterial when compared to poly-ether-ether-ketone (PEEK) or titanium (Ti).

Published Data Enables Significant Expansion of Biomaterial Claims for Amedica’s FDA 510(K)-Cleared Devices

September 14, 2012 3:14 pm | by Amedica Corporation | News | Comments

Amedica Corporation, a spinal and reconstructive implant manufacturer, announced today the expansion of biomaterial claims for its FDA 510(k)-cleared Valeo® Interbody Fusion Devices. The expansion of these claims focus on the innate properties of the Company’s proprietary Silicon Nitride (Si3N4) biomaterial, which has been proven to provide superior osteointegration and anti-infective capabilities...

A Brain Implant that Thinks

September 13, 2012 7:05 pm | by Massachusetts Institute of Technology | News | Comments

Researchers have used a neural implant to recapture a lost decision-making process in monkeys—demonstrating that a neural prosthetic can recover cognitive function in a primate brain. The results suggest that neural implants could one day be used to recover specific brain functions in patients with brain injuries or localized brain disease.


QIAGEN Teams with China's Lepu Medical to Provide Rapid Diagnosis of Heart Attacks Using Point of Need Testing

September 13, 2012 4:01 pm | by The Associated Press | News | Comments

QIAGEN's cutting-edge ESEQuant Lateral Flow System will run Lepu Medical's tests for key cardiac biomarkers to deliver lifesaving information in emergency rooms -- Cardiac testing adds further momentum for QIAGEN in fast-growing Chinese market -- Pioneering ESEQuant platform achieves first regulatory approval in human healthcare, expanding QIAGEN's global Point of Need business QIAGEN N.V.

West Announces the Commercial Launch of the Syringe Safety System Technology Platform

September 12, 2012 3:45 pm | by West Pharmaceutical Services | News | Comments

West, a leading global developer and manufacturer of components and systems for injectable drug delivery, announces the commercial introduction of its™ syringe safety system. West acquired the IP and rights to this system in 2011 and has completed the product development and first phase of commercial scale-up at its safety systems manufacturing center in France.

Scientists discover how the brain ages

September 12, 2012 3:38 pm | by Newcastle University | News | Comments

The ageing process has its roots deep within the cells and molecules that make up our bodies. Experts have previously identified the molecular pathway that react to cell damage and stems the cell's ability to divide, known as cell senescence. However, in cells that do not have this ability to divide, such as neurons in the brain and elsewhere, little was understood of the ageing process.

Automation GT designs micro solution for the treatment of Prostate Cancer

September 12, 2012 2:56 pm | by Automation GT | News | Comments

California based Life Science specialist, Automation GT, has developed automated machines to assist the manufacturing of products to treat prostate cancer. The machines, operating at micro-level, were developed for a medical company that specializes in the manufacture of products for cancer treatment. Automation GT designed automated systems to inspect and measure radioactive seeds...

Demand for Imaging in Healthcare Drives Sales of Imaging Agents

September 12, 2012 2:52 pm | by Kalorama Information | News | Comments

The market for contrast agents and radiopharmaceuticals is expected to sustain decent growth in the next few years, with much of that growth coming from the MRI, ultrasound and nuclear medicine modalities. Annual growth for medical contrast media during the next five years appears to be holding its own, despite the recession slowing capital equipment purchases.

Getting In Your Head: An Interview with Professor Edward S. Boyden

September 11, 2012 2:37 pm | by Jeff Reinke | Articles | Comments

Professor Edward S. Boyden is probably one of the few individuals on the planet who is actually best described as a brainiac. Currently serving as the principal investigator at the Massachusetts Institute of Technology’s Synthetic Neurobiology Group, Boyden’s mission is to develop tools for controlling and observing the dynamic circuits of the brain.

‘Invisible’ Hearing Aids are the Future

September 11, 2012 9:41 am | by GBI Research | News | Comments

Hearing aids are set to make big noise in the medical devices market, as innovative new technologies shrink hearing aids to turn up their cosmetic appeal, states a new report by medical devices experts GBI Research. The new report* states that growing elderly populations, government healthcare initiatives in emerging countries...

First Of Its Kind ARAMIS Cervical Disc Prosthesis—Revolutionary Cervical Disc Design Incorporates MOTIS High Performance Polymer to Reduce Wear Rate & Extend Service Life

September 11, 2012 9:36 am | by OSIMPLANT | News | Comments

OSIMPLANT today announced its selection of MOTIS® polymer (from Invibio® Biomaterial Solutions, the market leader in providing PEEK-based biomaterials to medical device manufacturers around the world), for its CE marked ARAMIS cervical disc prosthesis. The groundbreaking device is the first to incorporate an inlay made from carbon fiber-reinforced MOTIS polymer.

Cook Medical Launches Otolaryngology/Head and Neck Surgery Division

September 10, 2012 2:56 pm | by BUSINESS WIRE | News | Comments

Cook Medical, a world leader in minimally invasive medical device technology, has launched its new Otolaryngology/Head and Neck Surgery (OHNS) clinical division to bring the benefits of the company’s devices for non-surgical procedures to a new group of physicians and the patients they treat. Recognizing the need for specialized minimally invasive devices in otolaryngology...

Memphis medical device start-up launches new surgical solution for ‘hammertoe’ deformity

September 10, 2012 2:52 pm | by PR NewsChannel | News | Comments

When podiatric surgeon Scott Roman, DPM, of the Ankle and Foot Centers of Georgia in Atlanta designed a new device for surgical repair of proximal interphalangeal joint flexion deformity, the often painful condition known as “hammertoe,” a professional associate urged him to contact Patrick Mullaney for assistance in launching the device. After all, Roman needed to stay focused on his thriving practice...

ENTrigue Surgical Announces Sinus Surgery Collaboration with fiagon GmbH

September 6, 2012 2:03 pm | by PRNewswire | News | Comments

ENTrigue Surgical, Inc., a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today a collaboration agreement with fiagon GmbH, a company based in Berlin, Germany, that develops and manufactures a new generation of intelligent and highly portable navigation systems for ENT...

K2M Launches SERENGETI Complex Spine Minimally Invasive Retractor System at Scoliosis Research Society 47th Annual Meeting

September 5, 2012 3:16 pm | by K2M | News | Comments

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced the launch of the SERENGETI® Complex Spine Minimally Invasive Retractor System at the Scoliosis Research Society (SRS) 47th Annual Meeting in Chicago.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.